Cargando…

Convergence of Plasma Metabolomics and Proteomics Analysis to Discover Signatures of High-Grade Serous Ovarian Cancer

SIMPLE SUMMARY: In-time diagnosing ovarian cancer, intractable cancer that has no symptoms can increase the survival of women. The aim of this study was to discover biomarkers from liquid biopsy samples using multi-omics approach, metabolomics and proteomics for the diagnosis of ovarian cancer. To v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahn, Hee-Sung, Yeom, Jeonghun, Yu, Jiyoung, Kwon, Young-Il, Kim, Jae-Hoon, Kim, Kyunggon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709037/ https://www.ncbi.nlm.nih.gov/pubmed/33228226 http://dx.doi.org/10.3390/cancers12113447

Ejemplares similares

Generating Detailed Spectral Libraries for Canine Proteomes Obtained from Serum and Urine
por: Ahn, Hee-Sung, et al.
Publicado: (2023)

A Proteomics-Based Analysis of Blood Biomarkers for the Diagnosis of COPD Acute Exacerbation
por: Kim, Soo Han, et al.
Publicado: (2021)

Comparative analysis of therapeutic effects between medium cut-off and high flux dialyzers using metabolomics and proteomics: exploratory, prospective study in hemodialysis
por: Kim, Hyo Jin, et al.
Publicado: (2021)

Differential Urinary Proteome Analysis for Predicting Prognosis in Type 2 Diabetes Patients with and without Renal Dysfunction
por: Ahn, Hee-Sung, et al.
Publicado: (2020)

An Exploratory Pilot Study with Plasma Protein Signatures Associated with Response of Patients with Depression to Antidepressant Treatment for 10 Weeks
por: Kim, Eun Young, et al.
Publicado: (2020)

Plasma Protein Biomarkers Associated with Higher Ovarian Cancer Risk in BRCA1/2 Carriers
por: Ahn, Hee-Sung, et al.
Publicado: (2021)

Plasma Proteome Signature to Predict the Outcome of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
por: Gwark, Sungchan, et al.
Publicado: (2021)

Proteomic Discovery of Biomarkers to Predict Prognosis of High-Grade Serous Ovarian Carcinoma
por: Kim, Se Ik, et al.
Publicado: (2020)

Proteome profiling of low grade serous ovarian cancer
por: zadeh fakhar, Haniyeh Bashi, et al.
Publicado: (2019)

Dysregulation of X Chromosome Inactivation in High Grade Ovarian Serous Adenocarcinoma
por: Kang, Jun, et al.
Publicado: (2015)

Prognostic gene expression signature for high-grade serous ovarian cancer
por: Millstein, J., et al.
Publicado: (2020)

Space- and Time-Resolved Metabolomics of a High-Grade Serous Ovarian Cancer Mouse Model
por: Sah, Samyukta, et al.
Publicado: (2022)

Classification of High-Grade Serous Ovarian Carcinoma by Epithelial-to-Mesenchymal Transition Signature and Homologous Recombination Repair Genes
por: Sohn, Min-Hwan, et al.
Publicado: (2021)

Discovery of urine biomarkers for lupus nephritis via quantitative and comparative proteome analysis
por: Kwon, Oh Chan, et al.
Publicado: (2021)

Proteomic Discovery of Plasma Protein Biomarkers and Development of Models Predicting Prognosis of High-Grade Serous Ovarian Carcinoma
por: Kim, Se Ik, et al.
Publicado: (2023)

Genomic Rearrangement Signatures and Clinical Outcomes in High-Grade Serous Ovarian Cancer
por: Hillman, R Tyler, et al.
Publicado: (2017)

Cell Origins of High-Grade Serous Ovarian Cancer
por: Kim, Jaeyeon, et al.
Publicado: (2018)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

Clinical Interest of Combining Transcriptomic and Genomic Signatures in High-Grade Serous Ovarian Cancer
por: Kieffer, Yann, et al.
Publicado: (2020)

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
por: Sadlecki, Pawel, et al.
Publicado: (2018)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022)

Orthogonal Proteomic Platforms and Their Implications for the Stable Classification of High-Grade Serous Ovarian Cancer Subtypes
por: Thomas, Stefani N., et al.
Publicado: (2020)

Proteomic Studies on the Management of High-Grade Serous Ovarian Cancer Patients: A Mini-Review
por: Bradbury, Melissa, et al.
Publicado: (2021)

TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer
por: Lecuelle, Julie, et al.
Publicado: (2021)

Clinical significance of SPOCK2 expression signature for high-grade serous ovarian cancer patients
por: Jiao, Mi, et al.
Publicado: (2022)

Comparative Analysis of Proteomes and Phosphoproteomes in Patients with Prostate Cancer Using Different Surgical Conditions
por: Ahn, Hee-Sung, et al.
Publicado: (2022)

Proteomics analysis to reveal biological pathways and predictive proteins in the survival of high-grade serous ovarian cancer
por: Xie, Hongyu, et al.
Publicado: (2017)

Single-Cell Proteomics Analysis of Recurrent Low-Grade Serous Ovarian Carcinoma and Associated Brain Metastases
por: Pejovic, Tanja, et al.
Publicado: (2022)

A Robust Gene Expression Prognostic Signature for Overall Survival in High-Grade Serous Ovarian Cancer
por: Zhao, Yue, et al.
Publicado: (2019)

Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer
por: Pan, Jianbo, et al.
Publicado: (2020)

In vivo modeling of metastatic human high-grade serous ovarian cancer in mice
por: Kim, Olga, et al.
Publicado: (2020)

Impact of hemodynamic instability during cytoreductive surgery on survival in high-grade serous ovarian carcinoma
por: Kim, Se Ik, et al.
Publicado: (2022)

Targeting the Microenvironment in High Grade Serous Ovarian Cancer
por: Nwani, Nkechiyere G., et al.
Publicado: (2018)

The Tumor Microenvironment of High Grade Serous Ovarian Cancer
por: Stack, M. Sharon, et al.
Publicado: (2018)

High-grade serous ovarian cancer: the clone wars
por: Salomon-Perzyński, Aleksander, et al.
Publicado: (2017)

Molecular Management of High-Grade Serous Ovarian Carcinoma
por: Punzón-Jiménez, Paula, et al.
Publicado: (2022)

Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer
por: Kim, Se Ik, et al.
Publicado: (2019)

Machine Learning analysis of high-grade serous ovarian cancer proteomic dataset reveals novel candidate biomarkers
por: Farinella, Federica, et al.
Publicado: (2022)

Immune Modeling Analysis Reveals Immunologic Signatures Associated With Improved Outcomes in High Grade Serous Ovarian Cancer
por: James, Nicole E., et al.
Publicado: (2021)

Construction of an aging-related risk signature in high-grade serous ovarian cancer for predicting survival outcome and immunogenicity
por: Liu, Suxia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_il8oe7uj16cjoh2tqscaqhmfg6